Major Laboratories and Clinical & Translational Neurosciences Incubator
Showing 1-50 of 90 Results
-
Teddy J. Akiki, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Akiki's research focuses on advancing precision psychiatry through computational neuroscience approaches. His work centers on developing transformer-based foundation models for functional neuroimaging that can predict treatment responses and symptom trajectories in psychiatric disorders. Using multimodal connectomics (combining structural, functional, and diffusion MRI), he maps neural circuits underlying stress-related conditions, with particular emphasis on identifying dysconnectivity patterns in PTSD and depression. Dr. Akiki develops novel analytical methods for neuroimaging data, including network-restricted metrics and community detection frameworks optimized for functional time series. His translational work includes neuroimaging-augmented clinical trials of novel therapeutics for treatment-resistant psychiatric disorders, with the goal of implementing data-driven, personalized interventions based on individual neurobiological profiles.
-
Martijn Arns
Affiliate, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Visiting Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences IncubatorBioMartijn Arns, PhD, is an applied neuroscientist and entrepreneur with a longstanding focus on brain stimulation, neurofeedback/BCI, and medtech innovation. He is a Visiting Scholar at Stanford University, affiliated with the Stanford Brain Stimulation Lab and the Psychedelics and Consciousness Lab headed by Dr. Nolan Williams, dividing his time between Palo Alto and Nijmegen, the Netherlands.
In 2001, he founded the Brainclinics Foundation, a non-profit research institute dedicated to applied neuroscience from the clinic, to the clinic. His research and clinical work span interventional psychiatry, precision and stratified psychiatry, and novel interventions including rTMS for depression and OCD, TMS-induced Heart–Brain Coupling, neurofeedback, and psychedelics.
Dr. Arns has published over 190 scientific papers and holds four patents. He has successfully translated research into practice through multiple spin-off ventures. Beyond research and entrepreneurship, Dr. Arns contributes to the scientific community as associate editor for leading journals, organizer of international conferences, and board member of several professional organizations. He also advises medtech and AI start-ups and established companies, helping to advance translation and implementation in applied neuroscience. -
Nicholas Bassano
Adm Svcs Admstr 1, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordClinical Research Coordinator-2
Stanford University Department of Psychiatry and Behavioral Science
Brain Stimulation Lab -
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
-
Zaeda Blotner
Immigrant Child Health Program Administrator, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordImmigrant Child Health Program Administrator
-
Nicholas Branigan
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioMy research interests are at the intersection of neuroscience, statistics, and machine learning. In my current work, I develop and apply state-space models and drift-diffusion models to study large-scale brain networks with human fMRI and rodent fiber photometry.
-
Weidong Cai
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMy research program investigates the neurobiological basis of cognitive dysfunction across the lifespan, focusing on two critical populations: children with neurodevelopmental disorders (e.g., ADHD) and elders with neurodegenerative conditions (e.g., Parkinson’s disease). By employing a highly interdisciplinary approach that integrates cognitive science, advanced functional neuroimaging, and computational modeling, I aim to delineate the neurocognitive processes governing both typical and atypical brain development and aging. The ultimate goal is to advance our understanding of the factors contributing to cognitive deficits and translate these findings into improved diagnostic tools and precision treatment strategies.
-
Victor G. Carrión
John A. Turner Endowed Professor for Child and Adolescent Psychiatry
Current Research and Scholarly InterestsExamines the interplay between brain development and stress vulnerability via a multi-method approach that includes psychophysiology, neuroimaging, neuroendocrinology and phenomenology. Treatment development that focuses on individual and community-based interventions for stress related conditions in children and adolescents that experience traumatic stress.
-
John Coetzee
Social Science Research Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioJohn obtained his BA in Psychology from UC Berkeley, where he worked in a sleep and psychopathology lab. He then worked in a depression lab at UCSF before entering a PhD program at UCLA, where he conducted research on the relationship between language and thought under the guidance of Dr. Martin Monti. After completing his doctorate in Cognitive Neuroscience, he returned to the Bay Area where he currently is a postdoctoral researcher at the Palo Alto VA in the lab of Dr. Maheen Adamson, where he is developing new treatments for traumatic brain injury, and at Stanford in the Brain Stimulation Lab, where he is developing new treatments for depression. His current focus in both labs is on noninvasive neuromodulation.
-
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical and Translational Neurosciences Incubator)
Current Research and Scholarly InterestsMy lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
-
Karl Deisseroth
D. H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsKarl Deisseroth's laboratory created and developed optogenetics, hydrogel-tissue chemistry (beginning with CLARITY), and a broad range of enabling methods. He also has employed his technologies to discover the neural cell types and connections that cause adaptive and maladaptive behaviors.
-
Laramie Duncan
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsOur work is at the intersection of statistical genetics, psychiatry, and neuroscience. We use massive datasets and primarily computational approaches to identify mechanisms contributing to mental health problems like schizophrenia and depression. The overall goal of the lab is to discover fundamental information about psychiatric disorders, and ultimately to build more effective approaches to classification, prevention, and treatment.
-
Lara Foland-Ross
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am an Academic Research Scientist in Neuroscience and Precision Mental Health in the Department of Psychiatry and Behavioral Sciences at Stanford University. I use a variety of imaging modalities to examine the neural and behavioral mechanisms of mood and cognition. The primary aim of my work is to understand how individual brain patterns can be leveraged in treatment planning for depression. My primary projects include the ACE-D study ("Accelerating Cognition-guided signatures to Enhance translation in Depression") in the Stanford Center for Precision Mental Health and Wellness. I deeply value the process of acting on curiosity, learning from challenges, and applying creative solutions to both highlight and address gaps in our understanding of depression and other mental health conditions.
-
Lawrence Fung MD PhD
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsDr. Lawrence Fung is a physician-scientist specializing in autism and neurodiversity. Dr. Fung is an associate professor of Psychiatry at Stanford University. He is the director of the Stanford Neurodiversity Project (SNP), director of the Neurodiversity Clinic, and PI at the Fung Lab. Dr. Fung’s research traverses from multi-modal neuroimaging studies to a new conceptualization of neurodiversity and its application to clinical, educational, and employment settings. His lab has two main arms of research: (1) neurobiology of autism and (2) neurodiversity.
The neurobiology arm of his lab focuses on advancing the understanding of the thalamocortical circuits and their socio-communicative and cognitive functions in people on the spectrum by using novel neuroimaging and bioanalytical technologies. The findings of his neurobiology research efforts were published in top journals in our field, such as Molecular Psychiatry, Translational Psychiatry, and Psychoneuroendocrinology.
Using a community-based participatory research approach, Dr. Fung’s team devises and implements novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. He has developed and assessed several psychoeducational interventions, including the Developing Inclusive and Vocational Educational Resources for Success and Employment (DIVERSE) curriculum.
Dr. Fung is also the founding director of the SNP, a special initiative of the Department of Psychiatry at Stanford. Since 2017, the SNP has organized various events, including the Stanford Neurodiversity Summit, which brings thousands of people together yearly to share visions, innovations, and inspirations about maximizing the potential of neurodiversity. Each summer, about 100 high-school students join us at the SNP’s Research, Education, and Advocacy Camp for High Schoolers (SNP-REACH), to learn how to develop neurodiversity advocacy projects. Dr. Fung also teaches a neurodiversity design thinking course at Stanford. Clinically, Dr. Fung has applied the SBMN to his clinical work and is teaching a CME course focusing on delivering neurodiversity-affirmative care to neurodivergent patients. -
Rachel Hilton
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordResearch Nurse Practitioner- Precision Psychiatry for Williams PanLab, Department of Psychiatry and Behavioral Sciences- Stanford University
-
Andrew D. Huberman
Associate Professor of Neurobiology and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAndrew Huberman is a tenured associate professor of neurobiology and of ophthalmology at Stanford University School of Medicine, where he directs the Huberman Lab. After earning his B.A. from the University of California, Santa Barbara and completing M.A. and Ph.D. degrees in neuroscience at UC Berkeley and UC Davis, he conducted post-doctoral work at Stanford.
-
Robert Malenka
Nancy Friend Pritzker Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsLong-lasting changes in synaptic strength are important for the modification of neural circuits by experience. A major goal of my laboratory is to elucidate the molecular events that trigger various forms of synaptic plasticity and the modifications in synaptic proteins that are responsible for the changes in synaptic efficacy.
